These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29631910)

  • 1. Recent Advances in the Pathogenesis of Mucormycoses.
    Petrikkos G; Tsioutis C
    Clin Ther; 2018 Jun; 40(6):894-902. PubMed ID: 29631910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on mucormycosis pathogenesis.
    Ibrahim AS; Kontoyiannis DP
    Curr Opin Infect Dis; 2013 Dec; 26(6):508-15. PubMed ID: 24126718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucormycoses caused by Lichtheimia species.
    Schwartze VU; Jacobsen ID
    Mycoses; 2014 Dec; 57 Suppl 3():73-8. PubMed ID: 25186921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs.
    Roilides E; Antachopoulos C; Simitsopoulou M
    Mycoses; 2014 Dec; 57 Suppl 3():40-7. PubMed ID: 25175306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketoacidosis alone does not predispose to mucormycosis by Lichtheimia in a murine pulmonary infection model.
    Schulze B; Rambach G; Schwartze VU; Voigt K; Schubert K; Speth C; Jacobsen ID
    Virulence; 2017 Nov; 8(8):1657-1667. PubMed ID: 28750194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why.
    Radotra B; Challa S
    Curr Fungal Infect Rep; 2022; 16(4):206-220. PubMed ID: 36193101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host defenses against zygomycetes.
    Roilides E; Kontoyiannis DP; Walsh TJ
    Clin Infect Dis; 2012 Feb; 54 Suppl 1():S61-6. PubMed ID: 22247447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tornadic Shear Stress Induces a Transient, Calcineurin-Dependent Hypervirulent Phenotype in Mucorales Molds.
    Wurster S; Tatara AM; Albert ND; Ibrahim AS; Heitman J; Lee SC; Shetty AC; McCracken C; Graf KT; Mikos AG; Bruno VM; Kontoyiannis DP
    mBio; 2020 Jun; 11(3):. PubMed ID: 32605990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucormycosis--from the pathogens to the disease.
    Binder U; Maurer E; Lass-Flörl C
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():60-6. PubMed ID: 24476149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT; Muzny CA; Swiatlo E; Legendre DP
    Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary mucormycosis.
    Hamilos G; Samonis G; Kontoyiannis DP
    Semin Respir Crit Care Med; 2011 Dec; 32(6):693-702. PubMed ID: 22167397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucormycoses.
    Farmakiotis D; Kontoyiannis DP
    Infect Dis Clin North Am; 2016 Mar; 30(1):143-63. PubMed ID: 26897065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of Zygomycetes with innate immune cells reconsidered with respect to ecology, morphology, evolution and infection biology: a mini-review.
    Park HR; Voigt K
    Mycoses; 2014 Dec; 57 Suppl 3():31-9. PubMed ID: 25231056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mucormycete-host interface.
    Ibrahim AS; Voelz K
    Curr Opin Microbiol; 2017 Dec; 40():40-45. PubMed ID: 29107938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meeting the challenges of an emerging pathogen: the Henry Schueler 41&9 Foundation International Forum on Mucormycosis.
    Walsh TJ; Bloom BE; Kontoyiannis DP
    Clin Infect Dis; 2012 Feb; 54 Suppl 1():S1-4. PubMed ID: 22247440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances and Future Directions in the Understanding of Mucormycosis.
    Garre V
    Front Cell Infect Microbiol; 2022; 12():850581. PubMed ID: 35281441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host-iron assimilation: pathogenesis and novel therapies of mucormycosis.
    Ibrahim AS
    Mycoses; 2014 Dec; 57 Suppl 3(0 3):13-7. PubMed ID: 25178879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genes, Pathways, and Mechanisms Involved in the Virulence of Mucorales.
    Lax C; Pérez-Arques C; Navarro-Mendoza MI; Cánovas-Márquez JT; Tahiri G; Pérez-Ruiz JA; Osorio-Concepción M; Murcia-Flores L; Navarro E; Garre V; Nicolás FE
    Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32188171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 associated mucormycosis, host-iron assimilation: Probiotics can be a novel therapy.
    Bhardwaj A; Roy V
    Indian J Pharmacol; 2021; 53(5):415-416. PubMed ID: 34854413
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of mucormycosis (zygomycosis) in the 21st century].
    Ruiz Camps I; Salavert Lletí M
    Rev Iberoam Micol; 2018; 35(4):217-221. PubMed ID: 30471896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.